Skip to main content Back to Top
Advertisement

4/30/2018

Hydroxyzine Hydrochloride Injection

Products Affected - Description

    • Hydroxyzine hydrochloride intramuscular injection, American Regent, 50 mg/mL, 10 mL multiple dose vial, 25 count, NDC 00517-5610-25

Reason for the Shortage

    • American Regent is not currently marketing hydroxyzine 50 mg/mL 10 mL vials. They are the sole supplier of hydroxyzine injection.

Available Products

    • Hydroxyzine hydrochloride intramuscular injection, American Regent, 25 mg/mL, 1 mL vial, 25 count, NDC 00517-4201-25
    • Hydroxyzine hydrochloride intramuscular injection, American Regent, 50 mg/mL, 1 mL vial, 25 count, NDC 00517-5601-25
    • Hydroxyzine hydrochloride intramuscular injection, American Regent, 50 mg/mL, 2 mL vial, 25 count, NDC 00517-5602-25

Estimated Resupply Dates

    • American Regent has all marketed presentations of hydroxyzine injection available.

Updated

Updated April 30, 2018 by Michelle Wheeler, PharmD, Drug Information Specialist. Created March 8, 2017 by Michelle Wheeler, PharmD, Drug Information Specialist. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Vizient to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Vizient, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Vizient, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Vizient, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins